During the past decade, Retinal Consultants of Arizona conducted 28 clinical trials. In the 10-year time frame, 28 clinical trials started and 16 clinical trials were completed, i.e. on average, 57.1% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 8 clinical trials were completed. i.e. 88.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Retinal Consultants of Arizona" #1 sponsor was "Hoffmann-La Roche" with 6 trials, followed by "Clearside Biomedical, Inc." with 5 trials sponsored, "ThromboGenics" with 5 trials sponsored, "Retinal Consultants of Arizona" with 4 trials sponsored and "Santen Inc." with 4 trials sponsored. Other sponsors include 29 different institutions and companies that sponsored additional 29 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Retinal Consultants of Arizona" #1 collaborator was "MacuSight, Inc." with 4 trials as a collaborator, "National Eye Institute (NEI)" with 4 trials as a collaborator, "Genentech, Inc." with 3 trials as a collaborator, "Allergan" with 1 trials as a collaborator and "Juvenile Diabetes Research Foundation" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Retinal Consultants of Arizona" are "Diabetic Macular Edema" (11 trials), "Panuveitis" (6 trials), "Uveitis, Intermediate" (5 trials), "Uveitis, Posterior" (5 trials) and "Choroidal Neovascularization" (4 trials). Many other conditions were trialed in "Retinal Consultants of Arizona" in a lesser frequency.

Most popular intervention types in "Retinal Consultants of Arizona" are "Drug" (44 trials), "Other" (6 trials), "Biological" (5 trials), "Device" (5 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Ranibizumab" (5 trials), "LX211" (3 trials), "Sham" (3 trials) and "Sham Procedure" (3 trials). Other intervention names were less common.

The vast majority of trials in "Retinal Consultants of Arizona" are 58 trials for "All" genders.

Currently, there are NaN active trials in "Retinal Consultants of Arizona". undefined are not yet recruiting, 3 are recruiting, 3 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 41 completed trials in Retinal Consultants of Arizona, 1 suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Retinal Consultants of Arizona, 15 "Phase 1" clinical trials were conducted, 20 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 3 trials that are defined as “Not Applicable".